Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency (English, HTML)

View metadata and access the original English HTML file: Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-29

Decisions made about COVID-19 vaccines will follow processes established for reviews under the modified requirements for COVID-19 drugs. Health Canada will start rolling reviews to build towards a complete dossier for each vaccine. The dossier will include data to support the safety, efficacy and quality of the proposed vaccine.

Access original file